Effect of Shuxinyin (舒心饮) on In-Stent Restenosis after Coronary Artery Stenting

Objective: To evaluate the effect of anti-platelet regimens and it's combination with Shuxinyin (SXY, 舒心饮,) on in-stent restenosis after stent implantation. Methods: Forty-four patients with successful stent implantation in a coronary artery were randomly assigned to the treated group (n=20) and the control group (n=24). The treated group received: SXY and anti-platelet therapy. The control group were treated with anti-platelet regimens only. Platelet activation was assessed before and immediately after the stenting by flow cytometry, the expression of P-selectin (CD62P) and glycoprotein(GP) Ⅱb/Ⅲa receptor. It was reassessed on the 30th day after stenting. Plasma fibrinogen (Fg) and C-reaction protein (CRP) were measured by biuret and laser scattering turbidimetry respectively at the same time. Observation was made on the scoring of the symptoms of Qi deficiency syndrome, Qi-Yin deficiency syndrome and blood stasis syndrome in the two groups. Differences between groups were compared. Results: Compared with the control group, combination with SXY and anti-platelet therapy was remarkable in reducing plasma CRP (P<0.05), and also with the tendency to decrease plasma Fg, GPⅡb/Ⅲa and CD62P. It could also evidently decrease the scoring of Qi-Yin deficiency syndrome, Qi deficiency syndrome and blood stasis syndrome after stenting (P<0.05, 0.01, 0.01) respectively. Follow-up survey found 40% relapse of angina pectoris with 4 cases of in-stent restenosis proved by angiography in the treated group. But the relapse of angina pectoris in the control group was 67% with 2 cases of myocardial infarction (MI), 7 cases of in-stent restenosis proved by angiography and one death. Conclusions: Combination with SXY and anti-platelet regimens can prevent stent thrombosis and in-stent restenosis after stent implantation, and it seems superior to anti-platelet therapy only.     

麻痹性痴呆12例临床分析

目的探讨麻痹性痴呆(GPI)患者的临床表现,实验室检查、影像学、脑电图特征以及诊断、治疗及预后。方法回顾性分析经临床和实验室确诊的12例GPI患者的相关资料。结果GPI患者临床以智能障碍、精神异常、癫痫最常见。12例患者血清甲苯胺红凝集试验(TRUST)和梅毒螺旋体明胶凝集试验(TPPA)均( ),脑脊液TPPA均( ),而TRUST( )9例。头颅MRI检查结果示大脑皮质萎缩。3例以肢体抽搐为表现者脑电图可见广泛中高幅尖慢波,余脑电图为弥漫性慢波。经抗梅毒治疗,痊愈4例,显效5例,好转3例。结论GPI现已是我国神经梅毒分型中极常见类型,多见于中年男性,临床表现多变,早期误诊率高,早期发现、及时正规治疗预后好。     

“心衰康”对电镜下CHF模型心肌线粒体的影响

采用静注阿霉素造成的实验性心衰模型,利用电镜观察心衰康对心衰动物心肌线粒体的影响。结果：心衰康大剂组心肌线粒体比表面、体密度显降低（Ｐ〈０．０１、Ｐ〈０．０５）,低于心宝组,可见心衰康能明显消主衰动物模型心肌线粒体的肿胀,提示心衰康充血性心力衰竭的机制在于改善心肌细胞的三羟酸循环和氧化磷酸化过程,提高心肌中高能磷酸化合物ＡＴＰ和ＣＰ的含量,改善心脏舒缩功能。     

心衰康冲剂对实验性兔心力衰竭心功能及心钠素的影响

以红参、附子、川芎、葶苈子等药制成心衰康冲剂。选用３５只日本大耳白兔，随机分为５组，其中４组由耳缘静脉注射盐酸阿霉素造成充血性心力衰竭，以心衰康大剂量、小剂量作为治疗组，以心宝为治疗对照组，１５天为１个疗程。结果表明：造模后各组体重均有所增加，以造模组体重增加最为明显；心衰康及心宝均可明显降低兔的体重，改善一般状况，减慢心率，提高心脏功能，降低血浆心钠素水平，以心衰康大剂量的效果最好，心衰康小剂量与心宝作用相当。说明心衰康能改善充血性心力衰竭兔的心脏功能及心脏的内分泌功能，对充血性心力衰竭有一定的疗效。     

络风宁2号方对慢性心衰利尿剂抵抗患者临床疗效及安全性观察

目的 观察络风宁2号方对慢性心衰利尿剂抵抗患者的临床疗效及安全性.方法 将70例慢性心衰合并利尿剂抵抗患者随机分为治疗组35例,对照组35例.应用24 h尿量、体质量、血浆N-端脑的肽前体(NT-proBNP)、典型心衰症状量化评分、托拉塞米用量以及心衰患者的疗效评价标准以及电解质、肝肾功能等安全性指标作为评价指标,分...     

中医双心病房模式与入院全周期管理策略初探

<正>双心医学是心身医学的重要分支,又称为心理心脏病学或行为心脏病学,是研究和处理与心脏疾病相关的情绪、社会环境及行为问题的科学^[1]。当前越来越多的研究证实,心理健康不仅对心血管疾病本身具有影响,同时也对改善心血管健康和降低心血管疾病风险具有积极作用^[2]。     

缺血性络风内动证大鼠模型构建

目的 依据现代科学技术构建符合临床的、合理的、具有易行性和广泛适用性的缺血性络风内动证动物模型.方法 将70只体重为(260±20)g清洁级SD雄性大鼠随机分成模型组40只和假手术组30只,模型组开胸后将月桂酸钠(0.75 mg/ml)和同种异体血栓微颗粒(2.5 mg)的混合液0.2 ml注入其主动脉根部,假手术组注...     

从“络风内动”病机学说论治冠心病合并焦虑、抑郁

基于冠心病合并焦虑、抑郁的中医病机及“络风内动”的病机学说,探讨二者之间理论的相关性。论述“络损”——冠心病合并焦虑、抑郁发生发展的病因病机,络损日久引起“风动”增加急性心血管事件发生率,进一步阐明冠心病合并焦虑、抑郁与络损、风邪密切相关,总结辨证论治并探索相关风药的运用,以期为临床诊疗提供参考。     

心衰康对实验性心力衰竭心肌线粒体影响的电镜研究

心衰康对实验性心力衰竭心肌线粒体影响的电镜研究杨道文，孙建芝（河南中医学院郑州４５０００３）王显（河南省胸科医院中西医结合科郑州４５０００３）关键词：心衰康；阿霉素；实验性心衰；电子显微镜；心肌线粒体比表面；体密度；家兔近年来人们在探讨心衰发病机制时...     

正视网络

对新经济、新文化时代的大众来说,网络是一个无法回避的东西。两三年前还不知网络为何物的人,如今面对着这一全球信息化大潮的形态产物,既有“像雾像雨又像风”的朦胧感受,又有“天下情缘一线牵”的亲密感怀。当网络以一种以信息为标识的崭新生存方式出现在